Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-15

FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

FDA approved a supplemental application for HUMALOG MIX50/50 KWIKPEN (insulin lispro) from Eli Lilly.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HUMALOG MIX50/50 KWIKPEN (Insulin lispro)

Snippet

SUPPL AP for HUMALOG MIX50/50 KWIKPEN (INSULIN LISPRO)